Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SynOx Therapeutics
Biotech
BioNTech, SynOx plot paths to FDA as tumor trials hit goals
BioNTech is lining up a challenge to AstraZeneca and SynOx is planning to enter a field served by companies including Daiichi.
Nick Paul Taylor
Apr 13, 2026 5:10am
Trevena teeters on edge with C-suite shakedown—Chutes & Ladders
Nov 8, 2024 8:30am
SynOx taps chief medical, tech officers week after CEO hire
Aug 3, 2021 12:44pm
Bayer poaches Roche vet for early cancer R&D—Chutes & Ladders
Jul 30, 2021 9:30am
Ex-Kiadis CBO takes the helm at SynOx after $358M Sanofi buyout
Jul 27, 2021 11:14am
SynOx raises €37M to advance ex-Roche drug in rare tumor type
Nov 19, 2020 8:40am
